- Home
- SMSI vs CRIS Comparison
SMSI vs CRIS Comparison
Compare SMSI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMSI | CRIS |
|---|---|---|
| Founded | 1982 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.2M | 20.6M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SMSI | CRIS |
|---|---|---|
| Price | $0.89 | $0.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 109.6K | ★ 219.7K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.94 | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,363,000.00 | $9,898,000.00 |
| Revenue This Year | $13.97 | $27.10 |
| Revenue Next Year | $53.35 | $67.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.41 | $0.46 |
| 52 Week High | $1.30 | $3.13 |
Technical Indicators
Market Signals| Indicator | SMSI | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 62.49 | 45.38 |
| Support Level | $0.68 | $0.48 |
| Resistance Level | $0.93 | $0.63 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 82.16 | 55.04 |
Price Performance
Historical ComparisonAbout SMSI Smith Micro Software Inc.
Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.